Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 698-708

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated cannabinoid receptor 1 and G protein‐coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 3, 2015-03 ,pp. : 256-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 20, 2015-10 ,pp. : 4790-4805

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 565-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ‐opioid receptor sensitivity

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 17, 2015-09 ,pp. : 4419-4429

John Wiley & Sons Inc

Access to resources Recommend Favorite